Summit Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $31M | 1.4M | 21.90 |
| 2024-06-30 | $7.3M | 935k | 7.80 |
| 2024-03-31 | $4.2M | 1.0M | 4.14 |
| 2023-12-31 | $2.5M | 954k | 2.61 |
| 2023-09-30 | $1.8M | 941k | 1.87 |
| 2023-06-30 | $781k | 311k | 2.51 |
| 2023-03-31 | $26k | 15k | 1.75 |
| 2022-12-31 | $64k | 15k | 4.25 |
| 2022-03-31 | $151k | 61k | 2.46 |
| 2021-12-31 | $149k | 55k | 2.71 |
| 2021-09-30 | $276k | 55k | 5.02 |
| 2021-06-30 | $356k | 48k | 7.47 |